Myocardial laser revascularization in the Year 2000 as seen by a Norwegian specialist panel

Scandinavian Cardiovascular Journal

Volumn 35, Issue 1, 2001, Pages 14-18

  Wiseth, R ^a   Forfang, K ^a   Ilebekk, A ^a   Myhre, K I ^a   Nordrehaug, J E ^a   Sorlie D ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Angina pectoris; Lasers; Systemic review; Transmyocardial revascularization

Indexed keywords

PLACEBO;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE; HEALTH PRACTITIONER; HEART DENERVATION; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERPERSONAL COMMUNICATION; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SPECIALIST; MEDICAL TECHNOLOGY; MORBIDITY; MORTALITY; NORWAY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

HEART DISEASES; HUMANS; LASER SURGERY; MYOCARDIAL REVASCULARIZATION; NORWAY; SURVIVAL RATE;

EID: 0035061604     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/140174301750101384     Document Type: Article

References (37)

1. Transmyocardial revascularization: A new approach to myocardial revascularization
2. Transventricular revascularization by laser
3. Laser myocardial revascularization
4. Myocardial revascularization with laser: Preliminary findings
5. Cardiac allograft vasculopathy: The potential role for transmyocardial laser revascularization
6. 2 laser in patients with refractory angina pectoris, Clinical results from the Norwegian randomized trial
7. Transmyocardial laser revascularization in patients with refractory angina: A randomized controlled trial
8. 2 laser: One year results of a randomized controlled trial
9. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
10. Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status
11. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomized trial. ATLANTIC Investigators
12. Comparison of transmyocardial revascularization compared with medical therapy in patients with refractory angina
13. Factors correlating with risk of mortality after transmyocardial laser revascularization
14. Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up
15. Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary disease
16. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up
17. 2laser revascularization: A chance for the "inoperable" patient
18. The transmyocardial laser revascularization international registry report
19. Does blood flow through holmium-YAG transmyocardial laser channels?
20. 2 and holmium-YAG lasers
21. 2 laser
22. Transmyocardial laser revascularization: Histological features in human nonresponder myocardium
23. Histologic appearance of transmyocardial laser channels after 4 1/2 weeks
24. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia
25. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization
26. Angiogenesis and growth factor expression in a model of transmyocardial laser revascularization
27. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization
28. Angiogenesis in transmyocardial revascularization: Comparison of laser versus mechanical punctures
29. Myocardial revascularization by transmyocardial acupuncture. A physiologic impossibility
30. Nontransmural laser treatment incompletely denervates canine myocardium
31. Transmyocardial laser revascularization does not denervate the canine heart
32. Transmyocardial laser treatment damages intramyocardial nerve axons but spares epicardial pericoronary nerves
33. Cardiac sympathetic denervation after transmyocardial laser revascularization
34. New aspects of the placebo response in angina pectoris
35. The powerful placebo
36. Surgery as placebo